India Outperforms with High Growth and Low Volatility

India Outperforms with High Growth and Low Volatility

Morgan Stanley’s Chief Asia Equity Strategist Jonathan Garner explains why Indian equities are our most preferred market in Asia.


Read more insights from Morgan Stanley.


----- Transcript -----


Welcome to Thoughts on the Market. I’m Jonathan Garner, Morgan Stanley’s Chief Asia Equity Strategist. Today I’ll discuss why we remain positive on India’s long-term equity story.

It’s Tuesday, the 24th of June at 9am in Singapore.

We’ve had a long-standing bullish outlook on the India economy and its stock market. In the last five years MSCI India has delivered a total return in U.S. dollars of 145 percent versus 94 percent for global equities and just 39 percent for emerging markets. Indian equities are our most preferred market within Asia for three key reasons. First, India’s superior economic and earnings growth. Second, lower exposure to trade tariffs. And third, a strong domestic investor base. And all of this adds up to structural outperformance not just in Asia but indeed globally, and with significantly lower volatility than peer group markets.

So let’s dive deeper. To start with – the macroeconomic backdrop. We expect India to account for 20 percent of overall incremental global GDP growth in the coming decade. Manufacturing competitiveness is improving thanks to bolstered infrastructure in power, ports, roads, freight transport systems as well as investments in social infrastructure such as water, sewage and hospitals.

Additionally, India's growing middle class offers market opportunities to companies across many product categories. There’s robust domestic consumption, a strong investment cycle led by public and private capital expenditure and continuing structural reforms, including in the legal sphere. GDP growth in the first quarter was more than 7 percent and our team expects over 6 percent in the medium term, which would be by far the highest of the major economies.

Furthermore, we continue to expect robust corporate earnings growth. Since the end of COVID, MSCI India has delivered around 12 percent per annum [U.S.] dollar earnings per share growth versus low single digits for Emerging Markets overall. And we forecast 14 percent and 16 percent over the next two fiscal years. Growth drivers in the short term include an emerging private CapEx cycle, re-leveraging of corporate balance sheets, and a structural rise in discretionary consumption – signaling increased business and consumer confidence, after last year’s elections.

Another key reason that we’re positive on India currently is its lower-than-average vulnerability to ongoing trade and tariff disputes between the U.S. and its trade partners. Exports of goods to the U.S. amount to only 2 percent of India’s GDP versus, for example, 10 percent in Thailand or 14 percent in Taiwan. And India’s total goods exports are only around 12 percent of GDP. Moreover, for the time being, India’s very large services sector’s exports are not exposed to tariff actions, and are actually early beneficiaries of AI adoption.

Finally, India’s strong individual stock ownership means that there’s persistent retail buying, which underpins the equity market. Systematic Investment Plan (SIP) flows driven by a young urbanizing population are making new highs, and in May amounted to over U.S.$3 billion. They provide consistent capital inflows. That means that this domestic bid on stocks is unlikely to fade anytime soon.

This provides a strong foundation for the market and supports valuations which are slightly above emerging market averages. It also means that its market beta to global equities are low and falling, approximately 0.4 versus 1.1 ten years ago. And price volatility is well below other emerging markets. All told, making India an attractive play in volatile times.

Thanks for listening. If you enjoy the show, please leave us a review wherever you listen and share Thoughts on the Market with a friend or colleague today.

Avsnitt(1574)

Vishy Tirupattur: A Challenging Road for Commercial Real Estate

Vishy Tirupattur: A Challenging Road for Commercial Real Estate

As regional banks contend with sector volatility, commercial real estate could face challenges in securing new loans and refinancing debt when it matures.----- Transcript -----Welcome to Thoughts on t...

30 Mars 20233min

Lauren Schenk: Analyzing the Online Dating Market

Lauren Schenk: Analyzing the Online Dating Market

Many investors are questioning if the online dating market has become saturated and, in turn, if there is still a growth runway for the industry.----- Transcript -----Welcome to Thoughts on the Market...

29 Mars 20233min

Introducing: What Should I Do With My Money?

Introducing: What Should I Do With My Money?

If you're a listener to Thoughts on the Market you may be interested in our new podcast: What Should I Do With My Money? ----------------Managing our money can be ... a lot. It's one of the most impor...

29 Mars 20232min

Graham Secker: A Moment of Calm for European Equities

Graham Secker: A Moment of Calm for European Equities

Amid uncertainty in the global banking sector, are European equities a safe haven for investors to weather the storm?----- Transcript -----Welcome to Thoughts on the Market. I'm Graham Secker, Head of...

28 Mars 20233min

Mike Wilson: Is Banking Stress the Last Straw for the Bear Market?

Mike Wilson: Is Banking Stress the Last Straw for the Bear Market?

After the events of the past few weeks, earnings estimates look increasingly unrealistic and the bear market may finally be ready to appropriately factor-in elevated earning risks.----- Transcript ---...

27 Mars 20233min

Global Economy: Central Bank Policy in a Time of Volatility

Global Economy: Central Bank Policy in a Time of Volatility

As markets contend with the recent volatility in the banking sector, global central banks face the challenge of continuing to combat inflation against this updated backdrop. Chief Cross-Asset Strategi...

25 Mars 20239min

Special Encore: U.S. Pharmaceuticals - The Future of Genetic Medicine

Special Encore: U.S. Pharmaceuticals - The Future of Genetic Medicine

Original Release on February 6th, 2023: As new gene therapies are researched, developed and begin clinical trials, what hurdles must genetic medicine overcome before these therapies are commonly avail...

23 Mars 20238min

Global Thematics: Emerging Markets Face Rising Debt Levels

Global Thematics: Emerging Markets Face Rising Debt Levels

As investors focus on the risks of debt, can Emerging Markets combat pressure from wide fiscal deficits? Global Head of Fixed Income and Thematic Research Michael Zezas, Global Head of EM Sovereign Cr...

22 Mars 20236min

Populärt inom Business & ekonomi

badfluence
framgangspodden
varvet
rss-svart-marknad
rss-jossan-nina
rss-borsens-finest
uppgang-och-fall
svd-tech-brief
lastbilspodden
dynastin
avanzapodden
borsmorgon
rss-inga-dumma-fragor-om-pengar
fill-or-kill
24fragor
bathina-en-podcast
rss-dagen-med-di
rss-kort-lang-analyspodden-fran-di
rss-veckans-trade
tabberaset